StockMacro
Company, fund or insider

Help

Menu

Dentsply Sirona

$8.29 -17% in 6 monthsMarket cap $1.7B

XRAY on XNAS, Health Care, DENTSPLY SIRONA Inc., job postings

Measures activity, not value. Not investment advice.

Latest quarter revenue fell 7.5% to $836M while shares are down 16% in a year.

  • BadNet loss $121M over 12 months on $3.6B revenue
  • WatchDebt $2.2B against $195M cash; net debt $2B

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantology. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers.

Industry
Dental equipment & supplies (Health Care)
Employees
14,000
Website
dentsplysirona.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $836.0M, net loss $2.0M.
Quarter to 31 Dec 2021: revenue $1.1B, net income $119.0MQuarter to 31 Dec 2021: revenue $1.1B, net income $119.0MQuarter to 31 Mar 2022: revenue $969.0M, net income $69.0MQuarter to 31 Mar 2022: revenue $969.0M, net income $69.0MQuarter to 30 Jun 2022: revenue $1.0B, net income $73.0MQuarter to 30 Jun 2022: revenue $1.0B, net income $73.0MQuarter to 30 Sep 2022: revenue $947.0M, net income -$1.1BQuarter to 30 Sep 2022: revenue $947.0M, net income -$1.1BQuarter to 31 Dec 2022: revenue $983.0M, net income –Quarter to 31 Mar 2023: revenue $978.0M, net income -$19.0MQuarter to 31 Mar 2023: revenue $978.0M, net income -$19.0MQuarter to 30 Jun 2023: revenue $1.0B, net income $86.0MQuarter to 30 Jun 2023: revenue $1.0B, net income $86.0MQuarter to 30 Sep 2023: revenue $947.0M, net income -$266.0MQuarter to 30 Sep 2023: revenue $947.0M, net income -$266.0MQuarter to 31 Dec 2023: revenue $1.0B, net income –Quarter to 31 Mar 2024: revenue $953.0M, net income $18.0MQuarter to 31 Mar 2024: revenue $953.0M, net income $18.0MQuarter to 30 Jun 2024: revenue $984.0M, net income -$4.0MQuarter to 30 Jun 2024: revenue $984.0M, net income -$4.0MQuarter to 30 Sep 2024: revenue $951.0M, net income -$494.0MQuarter to 30 Sep 2024: revenue $951.0M, net income -$494.0MQuarter to 31 Dec 2024: revenue $905.0M, net income -$430.0MQuarter to 31 Dec 2024: revenue $905.0M, net income -$430.0MQuarter to 31 Mar 2025: revenue $879.0M, net income $20.0MQuarter to 31 Mar 2025: revenue $879.0M, net income $20.0MQuarter to 30 Jun 2025: revenue $936.0M, net income -$45.0MQuarter to 30 Jun 2025: revenue $936.0M, net income -$45.0MQuarter to 30 Sep 2025: revenue $904.0M, net income -$427.0MQuarter to 30 Sep 2025: revenue $904.0M, net income -$427.0MQuarter to 31 Dec 2025: revenue $961.0M, net income -$146.0MQuarter to 31 Dec 2025: revenue $961.0M, net income -$146.0MQuarter to 31 Mar 2026: revenue $880.0M, net income -$10.0MQuarter to 31 Mar 2026: revenue $880.0M, net income -$10.0MQuarter to 30 Jun 2026: revenue $898.0M, net income $37.0MQuarter to 30 Jun 2026: revenue $898.0M, net income $37.0MQuarter to 30 Sep 2026: revenue $836.0M, net income -$2.0MQuarter to 30 Sep 2026: revenue $836.0M, net income -$2.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $1.1B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$836.0M-$2.0M
30 Jun 2026$898.0M$37.0M
31 Mar 2026$880.0M-$10.0M
31 Dec 2025$961.0M-$146.0M
30 Sep 2025$904.0M-$427.0M
30 Jun 2025$936.0M-$45.0M
31 Mar 2025$879.0M$20.0M
31 Dec 2024$905.0M-$430.0M
30 Sep 2024$951.0M-$494.0M
30 Jun 2024$984.0M-$4.0M
31 Mar 2024$953.0M$18.0M
31 Dec 2023$1.0B–
30 Sep 2023$947.0M-$266.0M
30 Jun 2023$1.0B$86.0M
31 Mar 2023$978.0M-$19.0M
31 Dec 2022$983.0M–
30 Sep 2022$947.0M-$1.1B
30 Jun 2022$1.0B$73.0M
31 Mar 2022$969.0M$69.0M
31 Dec 2021$1.1B$119.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $3.6B $3.6B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -1.4% +9.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$121.0M -$882.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.61 -$4.39
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 50.5% 50.9% 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -1.5% -21.9% -9.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -3.4% -24.3% -7.6%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -8.5% -44.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $103.0M $80.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $195.0M $363.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $2.2B $2.4B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $2.0B $2.0B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.6 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $6.84
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.46 3.2
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.0 3.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.2 2.2
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 7.7% 1.6%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Dentsply SironaXRAY (this company) $1.7Bloss0.46-1.4%-3.4%
EnvistaNVST $3.7B5.81.3+9.8%22.0%
Agios PharmaceuticalsAGIO $1.7Bloss11.7+214%-265%
Healthcare ServicesHCSG $1.7B15.90.89+4.0%5.6%
Ultragenyx PharmaceuticalRARE $1.7Bloss2.3+16%-71.7%
LeMaitre VascularLMAT $1.7B26.66.3+12%23.5%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-7.5%

$836.0M vs $904.0M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-18%

$32.0M vs $39.0M (quarter ended 30 Sep 2026)

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+1.6%

372 13F filers vs 366

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

219.8M shares held by 13F filers (30 Sep 2026) of 198.2M outstanding (23 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

13%

26.2M shares sold short (30 Oct 2026) of 198.2M outstanding (23 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.4

26.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-12%

29.8M shares sold short in the report before, 26.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

70%

70% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 55%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

261

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-64%

10 vs 28 applications

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$12.0M

the 12 months before: $6.4M

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$20K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

16

16 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.3×

16 articles in the last 7 days; its usual week has 3.

Price $8.29 on 20 Nov 2026, -16% over 12 months (12-month range $8.29 to $14.68)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $624K in the last 12 months (the 12 months before: $350K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 10 published in the last 12 months, -64% on the 12 months before.
Revenue per quarter. Revenue $836.0M in the latest quarter, -7.5% on a year earlier.
Capital spending per quarter. Capital spending $32.0M in the latest quarter, -18% on a year earlier.
Institutional holders (13F filers). 372 13F filers reported holding it in the latest 13F quarter, -2.9% on a year earlier.
Federal obligations. Federal obligations: $13.0M published in the last 12 months, +106% on the 12 months before.
Lobbying spend. Lobbying spend: $20K published in the last 12 months, -80% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Jun 2026Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 451K)
11 Jun 20268-K and other filingsDirector or officer change
11 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 May 2026Sharp changeFirst award from a new federal agency: first award from a new federal agency (Department of Defense): DENTSPLY NORTH AMERICA LLC: new Department of Defense contract W81K0426FA188 ($2,262,436)
24 Feb 20268-K and other filingsDirector or officer change
3 Feb 2026Sharp changeShort interest spike: short interest spike, 14.7M vs usual 8.9M (2026-01-15); 1.7x the same period a year earlier
20 Jan 2026Lobbying filinglobbying engagement terminated (in-house)
13 Jan 2026Sharp changeShort interest spike: short interest spike, 15.0M vs usual 8.9M (2025-12-31); 1.5x the same period a year earlier
13 Jan 20268-K and other filingsDirector or officer change
19 Dec 2025Lobbying filinglobbying engagement terminated (FORBES-TATE)
16 Dec 2025Sharp changeShort interest spike: short interest spike, 14.2M vs usual 8.7M (2025-11-28); 1.7x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 13.5M vs usual 8.7M (2025-11-14); 1.4x the same period a year earlier
6 Nov 20258-K and other filingsDirector or officer change
3 Oct 20258-K and other filingsDirector or officer change
19 Sep 20258-K and other filingsDirector or officer change
21 Jul 20258-K and other filingsDirector or officer change
12 Jun 20258-K and other filingsA major agreement ended
29 May 20258-K and other filingsDirector or officer change
29 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Mar 2025Lobbying filingnew lobbying registration (in-house)
11 Mar 2025Lobbying filingnew lobbying registration (FORBES-TATE)
11 Mar 2025Sharp changeFirst lobbying registration: first lobbying registration: DENTSPLY SIRONA: new lobbying registration (FORBES-TATE)
6 Feb 20258-K and other filingsDirector or officer change
6 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Nov 20248-K and other filingsDirector or officer change
15 Oct 2024Sharp changeShort interest spike: short interest spike, 19.2M vs usual 12.1M (2024-09-30); 5.0x the same period a year earlier
20 Aug 20248-K and other filingsDirector or officer change
6 Aug 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 52.0M vs usual 36.0M (2024-06-30); 1.6x the same period a year earlier
31 Jul 20248-K and other filingsDirector or officer change
31 Jul 20248-K and other filingsRestructuring costs announced
31 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Mar 20248-K and other filingsChanged its auditor
29 Feb 20248-K and other filingsDirector or officer change
29 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Nov 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 908K)
2 Nov 20238-K and other filingsDirector or officer change
29 Sep 20238-K and other filingsDirector or officer change
29 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Apr 20238-K and other filingsDirector or officer change
12 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Feb 20238-K and other filingsRestructuring costs announced
13 Dec 2022Sharp changeShort interest spike: short interest spike, 12.0M vs usual 3.6M (2022-11-30); 5.8x the same period a year earlier
29 Nov 2022Sharp changeShort interest spike: short interest spike, 11.3M vs usual 3.6M (2022-11-15); 7.9x the same period a year earlier
15 Nov 2022Sharp changeShort interest spike: short interest spike, 11.6M vs usual 3.5M (2022-10-31); 5.6x the same period a year earlier
9 Nov 20228-K and other filingsReport will be filed late
1 Nov 2022Sharp changeShort interest spike: short interest spike, 11.9M vs usual 3.5M (2022-10-14); 5.3x the same period a year earlier
1 Nov 20228-K and other filingsEarlier financial statements can no longer be relied on
1 Nov 20228-K and other filingsAsset write-down (impairment)
18 Oct 2022Sharp changeShort interest spike: short interest spike, 11.1M vs usual 3.4M (2022-09-30); 4.9x the same period a year earlier
27 Sep 2022Sharp changeShort interest spike: short interest spike, 10.3M vs usual 3.3M (2022-09-15); 3.7x the same period a year earlier
22 Sep 20228-K and other filingsDirector or officer change
13 Sep 2022Sharp changeShort interest spike: short interest spike, 7.1M vs usual 3.2M (2022-08-31); 2.2x the same period a year earlier
7 Sep 2022Sharp changeFirst federal award: first federal award: DENTSPLY NORTH AMERICA LLC: new Department of Veterans Affairs contract 36C10G22K0052 ($3,703,179)
2 Sep 20228-K and other filingsDirector or officer change
30 Aug 2022Sharp changeShort interest spike: short interest spike, 6.7M vs usual 3.1M (2022-08-15); 2.2x the same period a year earlier
25 Aug 20228-K and other filingsDirector or officer change
16 Aug 2022Sharp changeShort interest spike: short interest spike, 6.8M vs usual 3.0M (2022-07-29); 2.8x the same period a year earlier
15 Aug 20228-K and other filingsDelisting notice or listing transfer
9 Aug 20228-K and other filingsDirector or officer change
9 Aug 20228-K and other filingsReport will be filed late
2 Aug 2022Sharp changeShort interest spike: short interest spike, 6.8M vs usual 2.9M (2022-07-15); 3.0x the same period a year earlier
19 Jul 2022Sharp changeShort interest spike: short interest spike, 6.0M vs usual 2.9M (2022-06-30); 2.8x the same period a year earlier
31 May 20228-K and other filingsDirector or officer change
18 May 20228-K and other filingsDelisting notice or listing transfer
10 May 20228-K and other filingsReport will be filed late
19 Apr 20228-K and other filingsDirector or officer change
11 Apr 20228-K and other filingsDirector or officer change
6 Apr 20228-K and other filingsDirector or officer change
24 Feb 20228-K and other filingsDirector or officer change
24 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Nov 2021: -$100K published
Month from 1 Dec 2021: $996K published
Month from 1 May 2022: -$274K published
Month from 1 Nov 2022: $189K published
Month from 1 Mar 2023: -$157K published
Month from 1 May 2023: -$261K published
Month from 1 Nov 2023: $908K published
Month from 1 Jun 2024: $100K published
Month from 1 Aug 2024: $200K published
Month from 1 Nov 2024: $310K published
Month from 1 Mar 2025: $250K published
Month from 1 Nov 2025: $100K published
Month from 1 Dec 2025: -$916K published
Month from 1 Mar 2026: $1.0M published
Month from 1 Jun 2026: $516K published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 4 published
Quarter from 1 Jul 2022: 7 published
Quarter from 1 Oct 2022: 2 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Oct 2023: 6 published
Quarter from 1 Jan 2024: 3 published
Quarter from 1 Apr 2024: 3 published
Quarter from 1 Jul 2024: 5 published
Quarter from 1 Oct 2024: 3 published
Quarter from 1 Jan 2025: 4 published
Quarter from 1 Apr 2025: 8 published
Quarter from 1 Jul 2025: 12 published
Quarter from 1 Oct 2025: 4 published
Quarter from 1 Jan 2026: 2 published
Quarter from 1 Apr 2026: 1 published
Quarter from 1 Jul 2026: 4 published
Quarter from 1 Oct 2026: 3 published
Revenue per quarter
Quarter ended 31 Dec 2020: $1.1B; public on 8 Nov 2022
Quarter ended 31 Dec 2021: $1.1B, +2.5% on a year earlier; public on 8 Nov 2022
Quarter ended 31 Mar 2022: $969.0M, -5.6% on a year earlier; public on 8 Nov 2022
Quarter ended 30 Jun 2022: $1.0B, -4.1% on a year earlier; public on 8 Nov 2022
Quarter ended 30 Sep 2022: $947.0M, -11% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $983.0M, -11% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $978.0M, +0.9% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $1.0B, +0.5% on a year earlier; public on 8 Aug 2023
Quarter ended 30 Sep 2023: $947.0M, 0% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $1.0B, +3.0% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $953.0M, -2.6% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $984.0M, -4.3% on a year earlier; public on 1 Aug 2024
Quarter ended 30 Sep 2024: $951.0M, +0.4% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $905.0M, -11% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $879.0M, -7.8% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $936.0M, -4.9% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $904.0M, -4.9% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $961.0M, +6.2% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $880.0M, +0.1% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $898.0M, -4.1% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $836.0M, -7.5% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2022: $44.0M, +47% on a year earlier; public on 8 Nov 2022
Quarter ended 30 Jun 2022: $41.0M; public on 8 Nov 2022
Quarter ended 30 Sep 2022: $32.0M, -8.6% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Mar 2023: $39.0M, -11% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $33.0M, -20% on a year earlier; public on 8 Aug 2023
Quarter ended 30 Sep 2023: $37.0M, +16% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Mar 2024: $34.0M, -13% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $52.0M, +58% on a year earlier; public on 1 Aug 2024
Quarter ended 30 Sep 2024: $43.0M, +16% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Mar 2025: $19.0M, -44% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $32.0M, -38% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $39.0M, -9.3% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $41.0M; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $52.0M, +174% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $44.0M, +38% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $32.0M, -18% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 484; public on 14 Feb 2022
31 Mar 2022 report: 501; public on 16 May 2022
30 Jun 2022 report: 434; public on 15 Aug 2022
30 Sep 2022 report: 413; public on 14 Nov 2022
31 Dec 2022 report: 396; public on 14 Feb 2023
31 Mar 2023 report: 422; public on 15 May 2023
30 Jun 2023 report: 424; public on 14 Aug 2023
30 Sep 2023 report: 433; public on 14 Nov 2023
31 Dec 2023 report: 387; public on 14 Feb 2024
31 Mar 2024 report: 424; public on 15 May 2024
30 Jun 2024 report: 354; public on 14 Aug 2024
30 Sep 2024 report: 355; public on 14 Nov 2024
31 Dec 2024 report: 348; public on 14 Feb 2025
31 Mar 2025 report: 342; public on 15 May 2025
30 Jun 2025 report: 375; public on 14 Aug 2025
30 Sep 2025 report: 383; public on 14 Nov 2025
31 Dec 2025 report: 338; public on 17 Feb 2026
31 Mar 2026 report: 370; public on 15 May 2026
30 Jun 2026 report: 366; public on 14 Aug 2026
30 Sep 2026 report: 372; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $688K published
Month from 1 Dec 2021: $4.3M published
Month from 1 Jan 2022: $670K published
Month from 1 Feb 2022: $321K published
Month from 1 Mar 2022: $671K published
Month from 1 Apr 2022: $705K published
Month from 1 May 2022: $1.3M published
Month from 1 Jun 2022: $1.3M published
Month from 1 Jul 2022: $1.3M published
Month from 1 Aug 2022: $1.7M published
Month from 1 Sep 2022: $2.8M published
Month from 1 Oct 2022: $2.7M published
Month from 1 Nov 2022: $2.6M published
Month from 1 Dec 2022: $8.5M published
Month from 1 Jan 2023: $337K published
Month from 1 Feb 2023: $365K published
Month from 1 Mar 2023: $573K published
Month from 1 Apr 2023: $441K published
Month from 1 May 2023: $990K published
Month from 1 Jun 2023: $573K published
Month from 1 Jul 2023: $1.8M published
Month from 1 Aug 2023: $2.2M published
Month from 1 Sep 2023: $2.0M published
Month from 1 Oct 2023: $3.2M published
Month from 1 Nov 2023: $3.6M published
Month from 1 Dec 2023: $4.0M published
Month from 1 Jan 2024: $206K published
Month from 1 Feb 2024: $8.7M published
Month from 1 Mar 2024: $1.0M published
Month from 1 Apr 2024: $813K published
Month from 1 May 2024: $540K published
Month from 1 Jun 2024: $600K published
Month from 1 Jul 2024: $709K published
Month from 1 Aug 2024: $442K published
Month from 1 Sep 2024: $331K published
Month from 1 Oct 2024: $537K published
Month from 1 Nov 2024: $621K published
Month from 1 Dec 2024: $1.1M published
Month from 1 Jan 2025: $123K published
Month from 1 Feb 2025: $978K published
Month from 1 Mar 2025: $339K published
Month from 1 Apr 2025: $253K published
Month from 1 May 2025: $430K published
Month from 1 Jun 2025: $273K published
Month from 1 Jul 2025: $607K published
Month from 1 Aug 2025: $289K published
Month from 1 Sep 2025: $545K published
Month from 1 Oct 2025: $839K published
Month from 1 Nov 2025: $567K published
Month from 1 Dec 2025: $915K published
Month from 1 Jan 2026: $110K published
Month from 1 Feb 2026: $238K published
Month from 1 Mar 2026: $1.2M published
Month from 1 Apr 2026: $556K published
Month from 1 May 2026: $2.8M published
Month from 1 Jun 2026: $712K published
Month from 1 Jul 2026: $340K published
Month from 1 Aug 2026: $1.9M published
Month from 1 Sep 2026: $3.2M published
Month from 1 Oct 2026: $978K published
Month from 1 Nov 2026: $110K published
Lobbying spend
Quarter from 1 Jul 2025: $80K published
Quarter from 1 Oct 2025: $20K published
Quarter from 1 Jan 2026: $20K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is workers named in WARN notices at 138 (8 Jan 2018), 2.7× its normal reading.
  • Clustered insider buying: had 4 insiders buy $451K of its shares on the open market within 30 days (4 filings) Public on 16 Jun 2026.
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 10 published in the last 12 months, -64% on the 12 months before.
  • Revenue per quarter: Revenue $836.0M in the latest quarter, -7.5% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 89 insider trades

No trades in the last 90 days; the latest was filed 16 Jun 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
16 Jun 2026Clyde HoseinDirectorBuy6,500$9.99$65KForm 4
15 Jun 2026Brian P McKeonDirectorBuy10,000$10.12$101KForm 4
15 Jun 2026Betsy D HoldenDirectorBuy10,086$9.88$100KForm 4
15 Jun 2026Michael J BarberDirectorBuy15,175$9.89$150KForm 4
15 Jun 2026Brian T GladdenDirectorBuy9,985$10.02$100KForm 4
9 Mar 2026Gregory T LucierDirectorBuy15,000$12.45$187KForm 4
9 Mar 2026James D ForbesDirectorBuy5,000$12.48$62KForm 4
3 Mar 2026James D ForbesDirectorBuy5,000$13.47$67KForm 4

372 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 55 opened a position, 49 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.26.1M13.2%$231.5M-588K-2.2%
AQR Capital Management LLC11.8M5.97%$104.8M+1.4M+13%
Vanguard Portfolio Management LLC11.4M5.75%$101.0M-384K-3.3%
Fuller & Thaler Asset Management, Inc.9.8M4.93%$86.6M-2.9M-23%
State Street Corp9.2M4.66%$81.8M-50K-0.5%
Vanguard Capital Management LLC9.0M4.57%$80.2M+1,5460%
Ariel Investments, LLC8.7M4.39%$77.0M+665K+8.3%
Lazard Asset Management LLC6.2M3.15%$55.3M-2.0M-25%
Geode Capital Management, LLC5.4M2.73%$48.0M-238K-4.2%
Cooke & Bieler LP5.1M2.57%$45.1M-1.8M-27%

Federal contracts

All 3 federal contracts

1 new award in 12 months, $2.3M obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
20 Feb 2026Department of DefenseDepartment of the Army$2.3MEQUIPMENT MAINTENANCE FOR SIRONA DENTAL CAD/CAM SYSTEM. SERVICE INCLUDE ALL TECHNICAL AND ADMINISTRATIVE PERSONNEL, TEST MEASURING EQUIPMENT, SUPPLIES, FACILITIES, TRANSPORTATION, TOOLS, MATERIALS, AND SUPERVISION AND TRAINING.USAspending
8 Nov 2023Department of Veterans Affairs$8.2MEXPRESS REPORT: 04/2023 - 10/2023USAspending
1 Sep 2022Department of Veterans Affairs$3.7MEXPRESS REPORT: 07/01/2021 THRU 07/31/2022USAspending

Company events

All 77 company events

In 12 months: 3 director or officer changes, 2 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
9 Oct 2026Signed a major agreementSame filing: took on new debt8-K
11 Jun 2026Director or officer change8-K
24 Feb 2026Director or officer change8-K
13 Jan 2026Director or officer change8-K
31 Dec 2025Signed a major agreementSame filing: took on new debt8-K
6 Nov 2025Director or officer change8-K
3 Oct 2025Director or officer change8-K
19 Sep 2025Director or officer change8-K

261 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 27%, Manufacturing & production 7%, Customer success & support 6%, Supply chain & procurement 3%.

PostedJobLocation
21 Nov 2026or earlierManufacturing Mechanical EngineerManufacturing & productionYork, PA, US, 17404
21 Nov 2026or earlierTerritory Sales Representative, Essential DentistrySales & business developmentUSA Home Office, --, US, NA
21 Nov 2026or earlierTeamleiter Produktion (m/w/d)Operations & administrationKonstanz, DE, 78467
21 Nov 2026or earlierTool & Die Maintenance MechanicManufacturing & productionYork, PA, US, 17404
21 Nov 2026or earlierMaterial Handler ISupply chain & procurementYork, PA, US, 17404
21 Nov 2026or earlierQuality Specialist Complaints (m/f/d)Test, quality & reliabilityBensheim, DE, 64625
21 Nov 2026or earlierSite Reliability EngineerSRE, DevOps & infrastructureWaltham, MA, US, 2451
21 Nov 2026or earlierOrthodontics and Digital Workflow Sales Specialist ValenciaSales & business developmentSpain Home Office, ES, NA

Reported lobbying spend: $20K in Q4 2025, $20K in Q3 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Dec 2025EndedDentsply Sirona Inc.its own lobbyistsCompetitive bidding for urological products, trace and tariffsHealth issuesFiling
18 Dec 2025EndedForbes-Tatefor Dentsply SironaIssues related to dental services; Issues related to competitive bidding proposed changes.; Issues related to dental services under Medicare Advantage; Issues related to competitive bidding proposed changes.; Issues related to international trade and tariff policy regarding dental supplies with the European Union, Canada, & Mexico.Health issues, Medicare/Medicaid, TradeFiling
25 Feb 2025NewForbes-Tatefor Dentsply SironaIssues related to dental supplies.Health issues, Medicare/Medicaid, TradeFiling
5 Feb 2025NewDentsply Sirona Inc.its own lobbyistsOral healthcare coverage, trade, tax.Health issues, Manufacturing, MED, TradeFiling

Layoff notices

All 2 layoff notices

No notice in 12 months; the latest is dated 11 Jan 2018. State WARN notices.

NoticeSiteWorkersJobs endSource
11 Jan 2018Dentsply Sirona Midwest DivisionCook County, IL1381 Mar 2018layoffNotice
8 Feb 2006Dentsply International IncCook County, IL511 Apr 2006closureNotice

The 5 newest of 202 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

16 Jun 2026confirmed

Confirmed across sources Government contracts and Insiders

Dentsply Sirona (XRAY): won its first award from the Department of Defense, a $2.3M contract, after 2 earlier federal awards from other agencies, while it had 4 insiders buy $451K of its shares on the open market within 30 days (4 filings). Two unrelated kinds of activity within 24 days.

  • Government contracts: First award from a new federal agency, became public on 23 May 2026
  • Insiders: Clustered insider buying, became public on 16 Jun 2026
See the evidence (2 changes)

Government contracts: First award from a new federal agency became public on 23 May 2026

Dentsply Sirona won its first award from the Department of Defense, a $2.3M contract, after 2 earlier federal awards from other agencies.

Source coverage starts
7 Oct 2007
Earlier events of other kinds
2

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Insiders: Clustered insider buying became public on 16 Jun 2026

Dentsply Sirona had 4 insiders buy $451K of its shares on the open market within 30 days (4 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$451K
Window
17 May 2026 to 16 Jun 2026

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

7 Sep 2022confirmed

Confirmed across sources Government contracts and Short interest and volume

Dentsply Sirona (XRAY): won its first federal award in our data, a $3.7M Department of Veterans Affairs contract, while it had 10.3M shares sold short in the 15 Sep 2022 report, 3.7× the same report last year. Two unrelated kinds of activity within 119 days.

  • Short interest and volume: Short interest spike, became public on 10 Aug 2022
  • Short interest and volume: Short interest spike, became public on 25 Aug 2022
  • Government contracts: First federal award, became public on 7 Sep 2022
  • Short interest and volume: Short interest spike, became public on 13 Sep 2022
  • Short interest and volume: Short interest spike, became public on 27 Sep 2022
  • Short interest and volume: Short interest spike, became public on 13 Oct 2022
  • Short interest and volume: Short interest spike, became public on 26 Oct 2022
  • Short interest and volume: Short interest spike, became public on 10 Nov 2022
  • Short interest and volume: Short interest spike, became public on 26 Nov 2022
  • Short interest and volume: Short interest spike, became public on 10 Dec 2022
2021-08-31: 3.2M2021-09-15: 2.8M2021-09-30: 2.3M2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M2022-09-15: 10.3M
The 15 Sep 2022 report against the 24 reports before it. this reportearliernormal: 3.3M
See the evidence (10 changes)

Short interest and volume: Short interest spike became public on 10 Aug 2022

Dentsply Sirona had 6.8M shares sold short in the 29 Jul 2022 report, 2.8× the same report last year.

This period
6.8M (the 29 Jul 2022 report)
Normal report (median of 24 earlier)
3.0M
Typical spread (median absolute deviation)
572K
How far from its usual level
+4.5
Same report last year
2.4M
History used
1,673 days
2021-07-15: 2.3M2021-07-30: 2.4M2021-08-13: 3.0M2021-08-31: 3.2M2021-09-15: 2.8M2021-09-30: 2.3M2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M
the 29 Jul 2022 report24 earlier reportsnormal: 3.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Aug 2022

Dentsply Sirona had 6.7M shares sold short in the 15 Aug 2022 report, 2.2× the same report last year.

This period
6.7M (the 15 Aug 2022 report)
Normal report (median of 24 earlier)
3.1M
Typical spread (median absolute deviation)
539K
How far from its usual level
+4.5
Same report last year
3.0M
History used
1,690 days
2021-07-30: 2.4M2021-08-13: 3.0M2021-08-31: 3.2M2021-09-15: 2.8M2021-09-30: 2.3M2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M
the 15 Aug 2022 report24 earlier reportsnormal: 3.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Government contracts: First federal award became public on 7 Sep 2022

Dentsply Sirona won its first federal award in our data, a $3.7M Department of Veterans Affairs contract.

Source coverage starts
7 Oct 2007
Earlier events of other kinds
0

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Short interest and volume: Short interest spike became public on 13 Sep 2022

Dentsply Sirona had 7.1M shares sold short in the 31 Aug 2022 report, 2.2× the same report last year.

This period
7.1M (the 31 Aug 2022 report)
Normal report (median of 24 earlier)
3.2M
Typical spread (median absolute deviation)
591K
How far from its usual level
+4.4
Same report last year
3.2M
History used
1,706 days
2021-08-13: 3.0M2021-08-31: 3.2M2021-09-15: 2.8M2021-09-30: 2.3M2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M
the 31 Aug 2022 report24 earlier reportsnormal: 3.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Sep 2022

Dentsply Sirona had 10.3M shares sold short in the 15 Sep 2022 report, 3.7× the same report last year.

This period
10.3M (the 15 Sep 2022 report)
Normal report (median of 24 earlier)
3.3M
Typical spread (median absolute deviation)
791K
How far from its usual level
+6.0
Same report last year
2.8M
History used
1,721 days
2021-08-31: 3.2M2021-09-15: 2.8M2021-09-30: 2.3M2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M2022-09-15: 10.3M
the 15 Sep 2022 report24 earlier reportsnormal: 3.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Oct 2022

Dentsply Sirona had 11.1M shares sold short in the 30 Sep 2022 report, 4.9× the same report last year.

This period
11.1M (the 30 Sep 2022 report)
Normal report (median of 24 earlier)
3.4M
Typical spread (median absolute deviation)
940K
How far from its usual level
+5.5
Same report last year
2.3M
History used
1,736 days
2021-09-15: 2.8M2021-09-30: 2.3M2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M2022-09-15: 10.3M2022-09-30: 11.1M
the 30 Sep 2022 report24 earlier reportsnormal: 3.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Oct 2022

Dentsply Sirona had 11.9M shares sold short in the 14 Oct 2022 report, 5.3× the same report last year.

This period
11.9M (the 14 Oct 2022 report)
Normal report (median of 24 earlier)
3.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.9
Same report last year
2.2M
History used
1,750 days
2021-09-30: 2.3M2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M2022-09-15: 10.3M2022-09-30: 11.1M2022-10-14: 11.9M
the 14 Oct 2022 report24 earlier reportsnormal: 3.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Nov 2022

Dentsply Sirona had 11.6M shares sold short in the 31 Oct 2022 report, 5.6× the same report last year.

This period
11.6M (the 31 Oct 2022 report)
Normal report (median of 24 earlier)
3.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.4
Same report last year
2.1M
History used
1,767 days
2021-10-15: 2.2M2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M2022-09-15: 10.3M2022-09-30: 11.1M2022-10-14: 11.9M2022-10-31: 11.6M
the 31 Oct 2022 report24 earlier reportsnormal: 3.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Nov 2022

Dentsply Sirona had 11.3M shares sold short in the 15 Nov 2022 report, 7.9× the same report last year.

This period
11.3M (the 15 Nov 2022 report)
Normal report (median of 24 earlier)
3.6M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+3.9
Same report last year
1.4M
History used
1,782 days
2021-10-29: 2.1M2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M2022-09-15: 10.3M2022-09-30: 11.1M2022-10-14: 11.9M2022-10-31: 11.6M2022-11-15: 11.3M
the 15 Nov 2022 report24 earlier reportsnormal: 3.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Dec 2022

Dentsply Sirona had 12.0M shares sold short in the 30 Nov 2022 report, 5.8× the same report last year.

This period
12.0M (the 30 Nov 2022 report)
Normal report (median of 24 earlier)
3.6M
Typical spread (median absolute deviation)
1.4M
How far from its usual level
+4.2
Same report last year
2.1M
History used
1,797 days
2021-11-15: 1.4M2021-11-30: 2.1M2021-12-15: 2.4M2022-01-14: 3.4M2022-01-31: 3.5M2022-02-15: 3.6M2022-02-28: 4.1M2022-03-15: 3.4M2022-03-31: 3.3M2022-04-14: 3.6M2022-04-29: 2.8M2022-05-13: 2.5M2022-05-31: 2.9M2022-06-15: 3.6M2022-06-30: 6.0M2022-07-15: 6.8M2022-07-29: 6.8M2022-08-15: 6.7M2022-08-31: 7.1M2022-09-15: 10.3M2022-09-30: 11.1M2022-10-14: 11.9M2022-10-31: 11.6M2022-11-15: 11.3M2022-11-30: 12.0M
the 30 Nov 2022 report24 earlier reportsnormal: 3.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

31 May 2019confirmed

Confirmed across sources Insiders and Institutional holdings

Dentsply Sirona (XRAY): saw 80 13F filers open a new position in the quarter ended 31 Mar 2019, 1.2× the same quarter last year, while it had 3 insiders buy $1.3M of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 9 days.

  • Institutional holdings: Many funds opening a new position, became public on 15 May 2019
  • Insiders: Clustered insider buying, became public on 31 May 2019
2017-03-31: 392017-06-30: 432017-09-30: 382017-12-31: 592018-03-31: 682018-06-30: 402018-09-30: 612018-12-31: 422019-03-31: 80
The quarter ended 31 Mar 2019 against the 8 quarters before it. this quarterearliernormal: 42.5
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 15 May 2019

Dentsply Sirona saw 80 13F filers open a new position in the quarter ended 31 Mar 2019, 1.2× the same quarter last year.

This period
80 (the quarter ended 31 Mar 2019)
Normal quarter (median of 8 earlier)
42.5
Typical spread (median absolute deviation)
4
How far from its usual level
+6.3
Same quarter last year
68
History used
2,008 days
2017-03-31: 392017-06-30: 432017-09-30: 382017-12-31: 592018-03-31: 682018-06-30: 402018-09-30: 612018-12-31: 422019-03-31: 80
the quarter ended 31 Mar 20198 earlier quartersnormal: 42.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Insiders: Clustered insider buying became public on 31 May 2019

Dentsply Sirona had 3 insiders buy $1.3M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$1.3M
Window
1 May 2019 to 31 May 2019

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 19 Jun 2026Insiders record

    MAZELSKY JONATHAN JAY (director) bought 10,000 shares of XRAY ($101,400) [amended] (dated 18 Jun 2026)

  2. 17 Jun 2026Insiders record

    HOSEIN CLYDE (director) bought 6,500 shares of XRAY ($64,935) (dated 16 Jun 2026)

  3. 16 Jun 2026several at once

    won its first award from the Department of Defense, a $2.3M contract, after 2 earlier federal awards from other agencies, while it had 4 insiders buy $451K of its shares on the open market within 30 days (4 filings). Two unrelated kinds of activity within 24 days.

    See the evidence (2 changes)

    Government contracts: First award from a new federal agency became public on 23 May 2026

    Dentsply Sirona won its first award from the Department of Defense, a $2.3M contract, after 2 earlier federal awards from other agencies.

    Source coverage starts
    7 Oct 2007
    Earlier events of other kinds
    2

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

    Insiders: Clustered insider buying became public on 16 Jun 2026

    Dentsply Sirona had 4 insiders buy $451K of its shares on the open market within 30 days (4 filings).

    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $451K
    Window
    17 May 2026 to 16 Jun 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  4. 16 Jun 2026Insiders change

    had 4 insiders buy $451K of its shares on the open market within 30 days (4 filings).

    Who bought: Gladden Brian T, Barber Michael J, Holden Betsy D, Mckeon Brian P.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $451K
    Window
    17 May 2026 to 16 Jun 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  5. 16 Jun 2026Insiders record

    MCKEON BRIAN P (director) bought 10,000 shares of XRAY ($101,200) (dated 15 Jun 2026)

  6. 16 Jun 2026Insiders record

    HOLDEN BETSY D (director) bought 10,086 shares of XRAY ($99,650) (dated 15 Jun 2026)

  7. 16 Jun 2026Insiders record

    Barber Michael J (director) bought 15,175 shares of XRAY ($150,081) (dated 15 Jun 2026)

  8. 16 Jun 2026Insiders record

    Gladden Brian T (director) bought 9,985 shares of XRAY ($100,050) (dated 15 Jun 2026)

  9. 11 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 11 Jun 2026Filings record

    Director or officer change

  11. 23 May 2026Government contracts change

    won its first award from the Department of Defense, a $2.3M contract, after 2 earlier federal awards from other agencies.

    See the evidence (1 source record)
    Source coverage starts
    7 Oct 2007
    Earlier events of other kinds
    2

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  12. 23 May 2026Government contracts record

    DENTSPLY NORTH AMERICA LLC: new Department of Defense contract W81K0426FA188 ($2.3M) (dated 20 Feb 2026)

  13. 10 Mar 2026Insiders record

    LUCIER GREGORY T (director) bought 15,000 shares of XRAY ($186,750) (dated 9 Mar 2026)

  14. 10 Mar 2026Insiders record

    Forbes James D (director) bought 5,000 shares of XRAY ($62,400) (dated 9 Mar 2026)

  15. 4 Mar 2026Insiders record

    Forbes James D (director) bought 5,000 shares of XRAY ($67,350) (dated 3 Mar 2026)

  16. 4 Mar 2026Insiders record

    LUCIER GREGORY T (director) bought 50,000 shares of XRAY ($707,562) (dated 3 Mar 2026)

  17. 24 Feb 2026Filings record

    Director or officer change

  18. 28 Jan 2026Short interest and volume change

    had 14.7M shares sold short in the 15 Jan 2026 report, 1.7× the same report last year.

    Same report last year: 8.6M; its normal report is 8.9M.

    See the evidence
    This period
    14.7M (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    8.9M
    Typical spread (median absolute deviation)
    1.0M
    How far from its usual level
    +3.9
    Same report last year
    8.6M
    History used
    2,939 days
    2025-01-15: 8.6M2025-01-31: 8.1M2025-02-14: 8.0M2025-02-28: 8.1M2025-03-14: 10.6M2025-03-31: 10.8M2025-04-15: 10.9M2025-04-30: 8.3M2025-05-15: 9.5M2025-05-30: 8.9M2025-06-13: 8.4M2025-06-30: 7.9M2025-07-15: 7.8M2025-07-31: 7.2M2025-08-15: 7.9M2025-08-29: 7.6M2025-09-15: 8.9M2025-09-30: 9.5M2025-10-15: 9.0M2025-10-31: 10.4M2025-11-14: 13.5M2025-11-28: 14.2M2025-12-15: 12.2M2025-12-31: 15.0M2026-01-15: 14.7M
    the 15 Jan 2026 report24 earlier reportsnormal: 8.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 20 Jan 2026Lobbying record

    DENTSPLY SIRONA INC.: lobbying engagement terminated (in-house) (dated 31 Dec 2025)

  20. 13 Jan 2026Short interest and volume change

    had 15.0M shares sold short in the 31 Dec 2025 report, 1.5× the same report last year.

    Same report last year: 9.8M; its normal report is 8.9M.

    See the evidence
    This period
    15.0M (the 31 Dec 2025 report)
    Normal report (median of 24 earlier)
    8.9M
    Typical spread (median absolute deviation)
    976K
    How far from its usual level
    +4.2
    Same report last year
    9.8M
    History used
    2,924 days
    2024-12-31: 9.8M2025-01-15: 8.6M2025-01-31: 8.1M2025-02-14: 8.0M2025-02-28: 8.1M2025-03-14: 10.6M2025-03-31: 10.8M2025-04-15: 10.9M2025-04-30: 8.3M2025-05-15: 9.5M2025-05-30: 8.9M2025-06-13: 8.4M2025-06-30: 7.9M2025-07-15: 7.8M2025-07-31: 7.2M2025-08-15: 7.9M2025-08-29: 7.6M2025-09-15: 8.9M2025-09-30: 9.5M2025-10-15: 9.0M2025-10-31: 10.4M2025-11-14: 13.5M2025-11-28: 14.2M2025-12-15: 12.2M2025-12-31: 15.0M
    the 31 Dec 2025 report24 earlier reportsnormal: 8.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 13 Jan 2026Filings record

    Director or officer change

  22. 19 Dec 2025Lobbying record

    DENTSPLY SIRONA: lobbying engagement terminated (FORBES-TATE) (dated 18 Dec 2025)

  23. 10 Dec 2025Short interest and volume change

    had 14.2M shares sold short in the 28 Nov 2025 report, 1.7× the same report last year.

    Same report last year: 8.5M; its normal report is 8.7M.

    See the evidence
    This period
    14.2M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    8.7M
    Typical spread (median absolute deviation)
    792K
    How far from its usual level
    +4.7
    Same report last year
    8.5M
    History used
    2,891 days
    2024-11-29: 8.5M2024-12-13: 8.7M2024-12-31: 9.8M2025-01-15: 8.6M2025-01-31: 8.1M2025-02-14: 8.0M2025-02-28: 8.1M2025-03-14: 10.6M2025-03-31: 10.8M2025-04-15: 10.9M2025-04-30: 8.3M2025-05-15: 9.5M2025-05-30: 8.9M2025-06-13: 8.4M2025-06-30: 7.9M2025-07-15: 7.8M2025-07-31: 7.2M2025-08-15: 7.9M2025-08-29: 7.6M2025-09-15: 8.9M2025-09-30: 9.5M2025-10-15: 9.0M2025-10-31: 10.4M2025-11-14: 13.5M2025-11-28: 14.2M
    the 28 Nov 2025 report24 earlier reportsnormal: 8.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 26 Nov 2025Short interest and volume change

    had 13.5M shares sold short in the 14 Nov 2025 report, 1.4× the same report last year.

    Same report last year: 9.9M; its normal report is 8.7M.

    See the evidence
    This period
    13.5M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    8.7M
    Typical spread (median absolute deviation)
    792K
    How far from its usual level
    +4.1
    Same report last year
    9.9M
    History used
    2,877 days
    2024-11-15: 9.9M2024-11-29: 8.5M2024-12-13: 8.7M2024-12-31: 9.8M2025-01-15: 8.6M2025-01-31: 8.1M2025-02-14: 8.0M2025-02-28: 8.1M2025-03-14: 10.6M2025-03-31: 10.8M2025-04-15: 10.9M2025-04-30: 8.3M2025-05-15: 9.5M2025-05-30: 8.9M2025-06-13: 8.4M2025-06-30: 7.9M2025-07-15: 7.8M2025-07-31: 7.2M2025-08-15: 7.9M2025-08-29: 7.6M2025-09-15: 8.9M2025-09-30: 9.5M2025-10-15: 9.0M2025-10-31: 10.4M2025-11-14: 13.5M
    the 14 Nov 2025 report24 earlier reportsnormal: 8.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 26 Nov 2025Insiders record

    VARON LESLIE F (director) bought 9,337 shares of XRAY ($99,999) (dated 25 Nov 2025)

  26. 6 Nov 2025Filings record

    Director or officer change

  27. 3 Oct 2025Filings record

    Director or officer change

  28. 19 Sep 2025Filings record

    Director or officer change

  29. 21 Jul 2025Filings record

    Director or officer change

  30. 12 Jun 2025Filings record

    A major agreement ended

  31. 29 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 29 May 2025Filings record

    Director or officer change

  33. 18 Mar 2025Lobbying record

    DENTSPLY SIRONA INC.: new lobbying registration (in-house) (dated 5 Feb 2025)

  34. 11 Mar 2025Lobbying change

    registered for federal lobbying for the first time in our data (Forbes-Tate).

    See the evidence (1 source record)
    Source coverage starts
    7 Oct 2008
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  35. 11 Mar 2025Lobbying record

    DENTSPLY SIRONA: new lobbying registration (FORBES-TATE) (dated 25 Feb 2025)

  36. 4 Mar 2025Insiders record

    LUCIER GREGORY T (director) bought 15,142 shares of XRAY ($249,994) (dated 3 Mar 2025)

  37. 6 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 6 Feb 2025Filings record

    Director or officer change

  39. 30 Jan 2025Insiders record

    LUCIER GREGORY T (director) bought 6,000 shares of XRAY ($110,130) [amended] (dated 29 Jan 2025)

  40. 19 Nov 2024Insiders record

    LUCIER GREGORY T (director) bought 6,000 shares of XRAY ($110,130) (dated 18 Nov 2024)

Showing the newest 40 of 145 entries; narrow the window or the kind of data to see older ones.

Not listed: 189 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000818479
Ticker
XRAY
Domain
dentsplysirona.com
Employer name
Dentsply International Inc, Dentsply Sirona, Inc., Dentsply Sirona Midwest Division (3 unverified)
Hq location
NC|CHARLOTTE|28277 (1 unverified)
Lobbying client
dentsply sirona
Name
100.SIRONA Immobilien GmbH, 101.Sirona Technologie GmbH & Co. KG, 102.SIRONA Verwaltungs GmbH, 103.Societe de Recherche Techniques Dentaires SAS and 128 more
Uei
JKNSTU7338Q9
Wikipedia
Dentsply Sirona
  • DOL H-1B labor condition applications and PERM certifications365 data points1 Oct 2019 to 21 Sep 2026
  • Federal lobbying disclosures (LDA)4 records, 11 data points5 Feb 2025 to 31 Dec 2025
  • SEC Form 13F institutional holdings3 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)193 records11 Jan 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1284 data points31 Dec 2006 to 23 Oct 2026
  • SEC Form 4 insider transactions89 records, 272 data points16 Mar 2016 to 18 Jun 2026
  • FINRA short interest (twice monthly)627 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards3 records, 14412 data points1 Oct 2007 to 16 Nov 2026
  • WARN layoff notices (state labor agencies)2 records, 6 data points6 Feb 2006 to 11 Jan 2018
  • Wikipedia pageviews10 data points11 Nov 2026 to 20 Nov 2026